Sales of respiratory medications key to predicting disease mortality, UK study finds

The value of integrating national longitudinal shopping data into respiratory disease forecasting models.

Argenx wins second FDA approval for Vyvgart in autoimmune nerve disease

After a string of clinical failures, the Dutch biotech argenx landed a much-needed win on Friday when the FDA approved its autoimmune disease drug, Vyvgart

June 22, 2024

Study reveals how tiny tweaks to actin shape our cells

Tiny things matter – for instance, one amino acid can completely alter the architecture of the cell. Researchers at the Universities of Göttingen and Warwick

December 22, 2023

Silo Pharma Announces Positive Results from Study for Depression Treatment, Remission, and Relapse Prevention | Psychedelic Invest

SARASOTA, FL, May 21, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug

May 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.